Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has bee ...

PHOENIX — Arizona is suing a major drug maker, accusing it of gaming the system by simply renaming an asthma drug to allow it ...

Arizona Attorney General Kris Mayes on Thursday sued drug producer GlaxoSmithKline (GSK) for predatory practices toward asthma patients, namely ...

Why does Hims seem to be able to ignore the statutes and rules that are enforced by the FDA and followed by every other ...

An estimated 5,000 people in the United States are living with Eosinophilic Granulomatosis with Polyangiitis (EGPA), a rare ...

PHOENIX — Arizona is suing a major drug maker, accusing it of gaming the system by simply renaming an asthma drug to allow it ...

PHOENIX – Arizona is suing a major drug maker, accusing it of gaming the system by simply renaming an asthma drug to allow it ...

In a report released on February 5, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with ...

Zentalis Pharmaceuticals, Inc.’s ZNTL share price has dipped by 11.11%, which has investors questioning if this is right time ...

The state’s top lawyer accused a British multinational drug company of “deceptive and unfair practices” that endangered lives and exploited American taxpayers.

The attorney general is accusing GlaxoSmithKline of allegedly violating the Arizona Consumer Fraud Act. PHOENIX — Arizona ...

GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, ...